INBX
Inhibrx Biosciences, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:52:29 AM EST
73.70USD+6.719%(+4.64)55,043
INBX Financials
In Q3 FY 2026 (ended ), Inhibrx Biosciences, Inc. Common Stock (INBX) reported revenue of $2M, net income of −$38.73M, operating cash flow of −$34.61M, and assets of $220.29M (filed ).
Loading financial statements…